Top compounds associated with response to MAL2


Feature Type Standardized
Nominal ANOVA
mRNA lapatinib CCLE pan-cancer AAC 0.47 4e-16
mRNA Erlotinib CCLE pan-cancer AAC 0.44 2e-13
mRNA austocystin d CTRPv2 pan-cancer AAC 0.25 3e-09
mRNA TW 37 GDSC1000 pan-cancer AAC -0.26 1e-08
mRNA canertinib CTRPv2 pan-cancer AAC 0.24 1e-08
mRNA PD 153035 CTRPv2 pan-cancer AAC 0.27 2e-08
mRNA EKB-569 GDSC1000 pan-cancer AAC 0.26 3e-08
mRNA KIN001-055 GDSC1000 pan-cancer AAC 0.25 1e-07
mRNA BIBW2992 CTRPv2 pan-cancer AAC 0.22 1e-07
mRNA GSK269962A GDSC1000 pan-cancer AAC -0.23 4e-07
Download CSV